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System dynamics is a powerful tool that allows modeling of complex and highly 
networked systems such as those found in the human immune system. We have 
developed a model that reproduces how the exposure of human monocytes to lipo-
polysaccharides (LPSs) induces an inflammatory state characterized by high produc-
tion of tumor necrosis factor alpha (TNFα), which is rapidly modulated to enter into a 
tolerant state, known as endotoxin tolerance (ET). The model contains two subsystems 
with a total of six states, seven flows, two auxiliary variables, and 14 parameters that 
interact through six differential and nine algebraic equations. The parameters were 
estimated and optimized to obtain a model that fits the experimental data obtained 
from human monocytes treated with various LPS doses. In contrast to publications on 
other animal models, stimulation of human monocytes with super-low-dose LPSs did 
not alter the response to a second LPSs challenge, neither inducing ET, nor enhanc-
ing the inflammatory response. Moreover, the model confirms the low production of 
TNFα and increased levels of C–C motif ligand 2 when monocytes exhibit a tolerant 
state similar to that of patients with sepsis. At present, the model can help us better 
understand the ET response and might offer new insights on sepsis diagnostics and 
prognosis by examining the monocyte response to endotoxins in patients with sepsis.
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inTrODUcTiOn
Endotoxin tolerance (ET) has been described as a transient state in which monocytes/macrophages 
are refractory to further stimulation with endotoxins such as lipopolysaccharides (LPSs), the major 
component of the outer membrane of Gram-negative bacteria (1, 2). ET has been studied in detail 
both in  vitro and in  vivo in animal models as well as in humans (3–6). This phenomenon takes 
place in several clinical situations, such as sepsis, in which the monocytes isolated from patients 
show a reduced production of proinflammatory cytokines in response to an ex vivo endotoxin chal-
lenge (7, 8). ET has also been reported in patients with acute coronary syndrome (9), cystic fibrosis 
(6, 10, 11), chronic lymphocytic leukemia (12), and stroke (13).
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Once the endotoxin is recognized by the receptors on the 
host monocyte/macrophage lineage, a signaling cascade is trig-
gered, resulting in the rapid expression of specific proinflam-
matory cytokines such as tumor necrosis factor alpha (TNFα) 
interleukin-12, (IL-12), IL-6, and IL-1β, and chemokines such as 
C–C motif ligand 2 (CCL2) and CXC motif ligand 12. However, 
the inflammatory response must be regulated to prevent damag-
ing systemic inflammation, also known as a “cytokine storm.” 
Thus, after the first wave of proinflammatory cytokines, the 
monocytes are functionally reprogrammed to produce cytokines 
with anti-inflammatory properties, such as IL-10 and transform-
ing growth factor β (TGF-β) (1, 2). The plasticity of these cells 
allows changes in the gene expression signatures that can be 
considered as various proinflammatory and anti-inflammatory 
phenotypes (14, 15). The anti-inflammatory phenotype and ET 
have been shown to be highly related and are orchestrated by 
common signaling pathways (16). Although CCL2 is primarily 
implicated in the recruitment of monocytes/macrophages to the 
inflammatory site (17, 18), it is highly expressed in the mono-
cytes from patients with sepsis, who show marked ET (19). In 
contrast, a distinct effect known as potentiation, in which the 
cells show an increased expression of proinflammatory cytokines 
in response to a second LPSs challenge, has been reported, 
particularly in mouse models (20–22). In humans, however, this 
phenomenon appears to be absent or weaker, probably because 
there are several differences in the inflammatory response to 
endotoxins between mice and humans (e.g., a higher endotoxin 
challenge is necessary in mice to achieve a similar response as is 
achieved in humans) (23, 24).
System dynamics has been proven to be a powerful instru-
ment for analyzing social, economic, ecological, and biological 
systems (25, 26), offering computerized models that allow 
systematic testing of various scenarios. Mathematical models 
have been previously used to study the inflammatory response, 
ET, and sepsis (27–30). However, these models were developed 
and tested using datasets from experiments using animals such 
as mice, rats, and swine (28, 29, 31, 32). Thus, the models might 
not be valid for humans, especially in regard to the differences in 
sensitivity to endotoxins and the potentiation phenomenon. To 
investigate the response of humans to endotoxins in depth, we 
modeled monocyte responses to endotoxins and their progres-
sion to an ET state using system dynamics. The model was tested 
using datasets obtained from experiments using human cells. The 
developed model is able to reproduce several real-life situations, 
such as the ET status of monocytes in patients with sepsis.
MaTerials anD MeThODs
Modeling
The model was developed following the four-step sequence 
proposed by the system dynamics methodology (25). First, 
experimental data and other evidence were used to create a 
mental modeling of the response of monocytes to endotoxins. 
Second, the model structure able to explain the polarization of 
the monocytes from the proinflammatory to the ET phenotype 
was represented as a Forrester diagram (Figure 1A). Third, the 
system was mathematically modeled as a continuous dynamic 
process represented by a set of differential and algebraic 
equations (Tables 1–3). Finally, the model was parameterized 
(Table 4), optimized, and validated to fit the experimental data 
from Figures 2–6 and findings published in previous articles 
(6, 33, 34). The parameters of the Hill function correspond-
ing to the activation rate were adjusted by using a non-linear 
regression analysis (Figure  3) to fit the experimental data 
summarized in Table  5. Similarly, the parameters of the Hill 
function corresponding to the TNF synthesis rate were adjusted 
by using a non-linear regression analysis (Figure 4C) to fit the 
estimated TNF synthesis rates for each LPSs concentration and 
summarized in Table 6. The rest of the model parameters were 
adjusted using the Vensim’s optimizer and Matlab to get the 
best match between model behavior and the data (Figures 4B 
and 5C). These adjustments were performed by minimizing 
the total quadratic error, which measures the goodness of the 
model. Finally, the model was validated using datasets from 
Figures 5B and 6.
The modeling process, simulations, and optimization analy-
ses were performed using Vensim DSS software, version 5.7a 
(Ventana Systems, Harvard, MA, USA) and Matlab R2015a 
(Mathworks, Inc., MA, USA).
Patients
Peripheral blood was obtained from three patients with sepsis 
(mean age ±  SD: 68 ±  10.6  years) who had microbiologically 
confirmed Gram-negative bacteremia (positive blood cultures 
for Escherichia coli), secondary to a urinary tract infection. The 
patients who met the consensus conference definition of sepsis 
(35) were admitted to the Department of Internal Medicine 
Service at La Paz University Hospital. Blood samples were col-
lected from the patients within 24  h of sepsis confirmation by 
blood culture. The following exclusion criteria were imposed: the 
presence of malignancy or chronic inflammatory diseases, treat-
ment with steroids or immunosuppressive drugs during the last 
month, hepatic failure (serum aspartate aminotransferase and/or 
alanine aminotransferase > 100 IU/l; prothrombin time < 60%; 
total bilirubin < 60 μmol/l), renal insufficiency (plasma creati-
nine > 200 μmol/l), HIV/AIDS, hepatitis B or C, pregnancy, and 
age > 80 years. Peripheral blood from 18 healthy volunteers was 
also obtained. Of them, 12 were used in setting up the model 
in Figures 2, 4 and 5, and the other 6 were used in validating 
the model in Figure  6. All the procedures were in accordance 
with the Helsinki Declaration of 2000, and informed consent was 
obtained from all the participants. This study was approved by the 
La Paz University Hospital Ethics Committee.
Peripheral Blood Mononuclear cells 
(PBMcs), Monocyte isolation, cell  
culture, and reagents
Peripheral blood mononuclear cells were isolated from healthy 
volunteers or sepsis patients by centrifugation on Ficoll-Hypaque 
Plus (Amersham Biosciences), and monocytes were obtained by 
adherence as previously described (6). The purity of the mono-
cyte cultures was tested by CD14 labeling and flow cytometry 
FigUre 1 | Graphical description using Vensim software of the subsystems describing (a) the various subsets of monocytes and (B) the levels of tumor necrosis 
factor and CCL2. Stock variables are represented inside boxes; flow variables are shown as double lines with an arrow and a valve symbol; the rest of the variables 
are auxiliary variables (inside circles), shadow variables (in gray between angled brackets), parameters (in bold), or initialization values (in gray); single lines with an 
arrow are used to specify that the destination variable is affected by the origin variable.
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TaBle 4 | Model parameters and their values.
N Parameter Value Units
1 Maximum activation rate 4.4990 Per hour
2 AC50 0.1889 Nanogram per milliliter
3 n 1.4825 Dimensionless
4 Immunomodulation rate 0.1088 Per hour
5 LPS removal rate 0.0726 Per hour
6 Maximum TNF synthesis rate 0.0071 Picogram per hour per 
monocyte
7 SC50 0.0890 Nanogram per milliliter
8 m 1.7670 Dimensionless
9 TD time delay in TNF 1 Hour
10 TNF degradation rate 0.1362 Per hour
11 CCL2 synthesis rate on resting 0.1315 · 10−3 Picogram per hour per 
monocyte
12 CCL2 synthesis rate on 
inflammation
0.1315 · 10−3 Picogram per hour per 
monocyte
13 CCL2 synthesis rate on ET 0.4633 · 10−2 Picogram per hour per 
monocyte
14 CCL2 degradation rate 0.2828 Per hour
TaBle 3 | Algebraic equation for the model auxiliary variable.
equation no. auxiliary variable equation Units
1 Activation rate
Activation rate
Maximum activation rate  LPS
AC
( )
( )
t
t n
n
=
+
·
50 LPS( )t n
Per hour
2 TNF synthesis rate TNF synthesis rate
Maximum TNF synthesis rate  LPS
( )
( )
t
t m
=
·
SC LPS50m mt+ ( )
Per hour
TaBle 2 | Algebraic equations of the model flows.
equation no. Flow equation Units
1 Activation Activation  Resting monocytes   Activation rate( ) ( ) ( )t t t= · Monocytes per hour
2 Immunomodulation Immunomodulation Proinflammatory monocytes Immunomod( ) ( )t t= ⋅ ulation rate Monocytes per hour
3 LPS removal LPS removal   LPS   LPS removal rate( ) ( )t t= · Nanogram per milliliter 
per hour
4 TNF production TNF production  = Proinflammatory monocytes TD time del( ) −t t ay in TNF  TNF synthesis rate ( ) ⋅ ( )t Picogram per hour
5 TNF degradation TNF  TNF   TNF degradation ratedegradation( ) ( )t t= · Picogram per hour
6 CCL2 production CCL2 production Resting monocytes CCL2 synthesis rat( ) ( )t t= ⋅ e 
on resting + Proinflammatory monocytes CCL2 synthesi( )t ⋅ s rate 
on inflammation + ET monocytes CCL2 synthesis r( )t ⋅ ate on ET
Picogram per hour
7 CCL2 degradation CCL2 degradation  CCL2   CCL2 degradation rate( ) ( )t t= · Picogram per hour
TaBle 1 | Differential equations of the model stocks.
equation no. stock equation Units
1 Resting monocytes d t
dt
t
Resting monocytes
Activation
( )
( )= −
Monocytes
2 Proinflammatory monocytes d t
dt
t
Proinflammatory monocytes
Activation Immunomodula
( )
( )= – tion( )t Monocytes
3 ET monocytes d t
dt
t
ET monocytes
Immunomodulation
( )
( )= Monocytes
4 LPS d t
dt
t
LPS
LPS removal
( )
( )= − Nanogram
5 TNF d t
dt
t t
TNF
TNF TNF degradationproduction
( )
( ) − ( )= Picogram
6 CCL2 d t
dt
t t
CCL2
CCL2 CCL2 degradationproduction
( )
( ) ( )= – Picogram
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analysis (average 82% CD14 + cells). Other cell surface markers 
were also tested (average CD1a = 4.1%, and CD89 = 85%). All 
the reagents used for the cell cultures were endotoxin-free, as 
assayed with the limulus amebocyte lysate test (Cambrex).
To establish the model parameters, the monocytes were treated 
with LPS concentrations ranging from 5 ng/ml to 0.5 pg/ml dur-
ing the times of stimulation (ts) indicated in Figure 2. After LPS 
treatment, the cells were washed three times with PBS and kept in 
complete medium for 16 h to ensure the monocytes entered into 
ET. The cells were then restimulated with 5 ng/ml LPS for 3 h and 
cytokine levels were quantified. The control cells were not treated 
with LPS during the first stimulation.
To compare the model output with experimental data, 
monocytes from healthy volunteers and patients with sepsis were 
treated once or twice with LPSs at the concentrations indicated 
in Figures 4–6. Samples of culture supernatant were collected at 
times ranging from 1 to 24 h to quantify the levels of TNFα and 
CCL2.
FigUre 2 | Continued
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FigUre 4 | Simulation of various proinflammatory scenarios. Experimental 
data were obtained from cultures of 106 monocytes isolated from healthy 
volunteers challenged with lipopolysaccharides (LPSs) as described in (a) at a 
concentration of 5, 0.25, 0.1, 0.05 ng/ml, or not challenged. Tumor necrosis 
factor (TNFα) levels were quantified in the monocyte cultures at the indicated 
times using cytometric bead array assays and were graphically represented 
(B) as black circles (LPSs 5 ng/ml), brown squares (LPSs 0.25 ng/ml), green 
triangles (LPSs 0.1 ng/ml), blue diamonds (LPSs 0.05 ng/ml), or red circles 
(not challenged). Real data were expressed as the mean ± SEM (n = 3 healthy 
volunteers). The model was programmed with 106 monocytes in the resting 
monocyte state and the same initial LPSs concentrations. Outputs from the 
model simulation for TNF state were graphically represented (B) as black line, 
LPSs 5 ng/ml; brown line, LPSs 0.25 ng/ml; green line, LPSs 0.1 ng/ml; blue 
line, LPSs 0.05 ng/ml; or red line, not challenged. The coefficient of 
determination R2 is presented in each case to measure the goodness of the 
adjustment. (c) Adjustment of the TNF synthesis rate Hill function. The black 
line corresponds to the function optimized to fit the estimated TNF synthesis 
rates from Table 6. [LPS] refers to the LPSs concentration in the medium.
FigUre 3 | Activation rate expressed as Hill function. The black line 
corresponds to the function optimized by dose–response non-linear 
regression analysis to fit estimated values (gray diamonds) shown in Table 5. 
The coefficient of determination R2 is presented. [LPS] refers to the 
lipopolysaccharides concentration in the first stimulus.
FigUre 2 | Continued  
The activation rate of monocytes treated with lipopolysaccharides (LPSs). (a) Schematic representation of the endotoxin tolerance (ET) model used. Human 
monocytes isolated from PMBCs were pretreated with (B) 5 ng/ml, (c) 2 ng/ml, (D) 1 ng/ml, (e) 0.5 ng/ml, or (F) 0.1 ng/ml LPS for the indicated times (time of 
stimulation, ts), washed twice with PBS, cultured in medium for 16 h, and restimulated with 5 ng/ml LPS for 3 h. The supernatants were then harvested and the 
tumor necrosis factor alpha (TNFα) levels were evaluated by cytometric bead array (CBA). Relative TNFα levels to control monocytes without LPS pretreatment 
(treated only with the second LPS stimulus at 5 ng/ml), were expressed as mean ± SEM (n = 3 healthy volunteers). **p < 0.01; ***p < 0.001 compared with the 
value for the control as assessed by ANOVA and Dunnett’s Multiple Comparison post-test. Curves fitting the experimental data were obtained by non-linear 
regression. The coefficient of determination R2 is presented in each case to measure the goodness of the adjustment. (g) Schematic representation of the ET model 
used for low-LPS doses. (h) Human monocytes isolated from PMBCs were pretreated with the indicated LPS concentrations for 16 h, washed twice with PBS, 
cultured in medium for 16 h, and restimulated with 5 ng/ml LPS for 3 h. The supernatants were then harvested and the TNFα levels were evaluated by CBA. Relative 
TNFα levels to control monocytes without LPS pretreatment (treated only with the second LPS stimulus at 5 ng/ml), were expressed as mean ± SEM (n = 3 healthy 
volunteers). **p < 0.01; ***p < 0.001 compared with the value for the control as assessed by ANOVA and Dunnett’s Multiple Comparison post-test.
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The LPS from Salmonella abortus was a kind gift from 
Dr. Galanos (Max Planck Institute for Immunobiology, Freiburg, 
Germany). All work with LPS was performed in biosafety level 
(BSL) two facilities under appropriate work practices, and proper 
use of personal protective equipment. The medium used for the 
cell culture was DMEM from Invitrogen.
cytometric Bead array (cBa)
The cytokine levels (TNFα and CCL2) in the culture supernatants 
from the human samples were determined using the CBA Flex 
Set (BD Biosciences) following the manufacturer’s protocol. 
The data collected were analyzed by flow cytometry, using a BD 
FACSCalibur flow cytometer (BD Biosciences).
statistical analysis of experimental Data
The data were collected and are expressed as mean ± SEM (n is 
indicated in each figure legend). The statistical significance was 
set at p < 0.05 and all statistical analyses were conducted using 
Prism 5.0 software (GraphPad) and Matlab.
resUlTs
Modeling
A dynamic compartmental model can be used to properly 
parameterize and describe several components of the immune 
FigUre 5 | Simulation of an endotoxin tolerance (ET) scenario. (a) Schematic representation of the ET model used for this study. The cultures of human monocytes 
were or not pretreated with 5 ng/ml LPSs for 8 h, washed twice with PBS, cultured in medium for 16 h, and restimulated with 5 ng/ml lipopolysaccharides. 
Supernatants were harvested at the indicated times, tumor necrosis factor alpha (TNFα) (B), and C–C motif ligand 2 (CCL2) (c) protein levels were evaluated by 
cytometric bead array and then graphically represented as black circles (control), blue triangles (ET), or red circles (basal). Real data were expressed as means 
experiments ± SEM (n = 3 healthy volunteers). To simulate the ET scenario, the model was programmed with 0, 75,000, and 925,000 monocytes in the resting 
monocytes state, the proinflammatory monocytes state, and the ET monocytes state, respectively. The control scenario was simulated as described in Figure 4. 
Outputs from TNF (B) and CCL2 (c) states were graphically represented as black line (control), blue line (ET), or red line (basal). The coefficient of determination R2 
was calculated in each case to measure the goodness of the adjustment and is presented in the graphs.
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The model also contains a second subsystem modeling the 
production of TNF (as a proinflammatory marker) and CCL2 
(as an ET marker) (Figure  1B). Because these cytokines are 
differentially synthesized by the three subsets of monocytes, this 
subsystem is used to indirectly monitor the dynamic process 
followed by monocytes modeled in the main subsystem. It is 
composed of two states (TNF and CCL2) and four flows (TNF 
production, TNF degradation, CCL2 production, and CCL2 
degradation), modifying the balance of these stocks.
The model structure, built with Vensim software (Figures 1A,B), 
contains the states and flows previously mentioned, two auxiliary 
variables (inside circle), and 14 parameters (in bold). These ele-
ments are linked by the physical flows (double line with arrow) 
and by the information transmissions (single line with arrow), 
according to the mathematical model represented by the set of 
differential and algebraic equations (Tables 1–3).
The six differential equations of Table  1 establish the mass 
balance (inflows minus outflows) in the compartments. The first 
three differential equations of Table  1 describe the changes in 
the number of monocytes in the three subgroups. Because LPS 
system (36, 37). In this sense, both physical sites and functions, 
such as the organs of the immune system and states of immune 
cell differentiation, respectively, can be schematized as a set of 
compartments.
To explain the transition of the peripheral blood monocytes 
through the various functional stages after an endotoxin challenge, 
we considered a dynamic model divided into two subsystems 
(Figures 1A,B). The main subsystem reproduces the activation/
immunomodulation process by which monocytes transit after 
endotoxin challenge. It contains four compartments (states) and 
three transitions (physical flows) between them (Figure  1A), 
which are based on various assumptions. First, the monocytes are 
classified into three subgroups: resting monocytes, proinflamma-
tory monocytes, and ET monocytes. Second, the transition from 
the resting monocytes to the proinflammatory monocytes (acti-
vation) only occurs when LPSs are present in the medium. Third, 
the flow between proinflammatory monocytes and ET monocytes 
(immunomodulation) is an LPS-independent process. Finally, we 
assumed that LPS concentration is not continually the same; thus, 
an outflow was included in the model (LPS removal).
FigUre 6 | Validation of the model by simulating endotoxin tolerance (ET) scenarios. (a) Schematic representation of the ET model used for this study. The 
cultures of human monocytes were or not pretreated with 0.5 ng/ml lipopolysaccharides (LPSs) for 30 min, washed twice with PBS, cultured in medium for 16 h, 
and restimulated with 5 ng/ml LPSs. Supernatants were harvested at the indicated times, tumor necrosis factor alpha (TNFα) (B), and C–C motif ligand 2 (CCL2) 
(c) protein levels were evaluated by cytometric bead array and then graphically represented as black circles (control) or gray triangles (ET). Real data were 
expressed as mean ± SEM (n = 3 healthy volunteers). The model was programmed with a total 106 monocytes and challenged with 5 ng/ml LPS. The Tolerance 
index was adjusted by an optimization process to 68% to minimize the sum of the standard quadratic errors for TNF and CCL2 simulations. Outputs for TNF  
(B) and CCL2 (c) states were graphically represented (gray lines). For comparison, simulation of 106 monocytes with a tolerance index equals to 0 and challenged 
with the same LPSs concentration was also represented as black lines. Cultures of 106 monocytes from patients with sepsis were stimulated with 5 ng/ml LPS, 
and TNF (D) and CCL2 (e) levels were measured after 16 h and then graphically represented as gray triangles. As control the results with 106 monocytes from 
healthy volunteers are also represented (black circles). Real data were expressed as mean ± SEM (n = 3). The model was programmed with a total 106 monocytes 
and challenged with 5 ng/ml LPS. The Tolerance index was adjusted as described above to 68%. Outputs for TNF (D) and CCL2 (e) states were graphically 
represented as gray lines. For comparison, simulation of 106 monocytes with a tolerance index equals to 0 and challenged with the same LPS concentration was 
also represented as black lines.
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concentration in the medium is known to decrease over time, 
changes in LPSs are also represented by a differential equation 
(Table 1, Eq. 4). Equations 5 and 6 of Table 1 express the changes 
in TNF and CCL2 levels per time unit, respectively.
The activation of monocytes after LPS stimulation depends 
directly on the stock of resting monocytes and the auxiliary 
variable activation rate (Table  2, Eq. 1). The activation rate is 
modulated by a Hill activation function (Table  3, Eq. 1). This 
expression depends on: the maximum activation rate, which 
allows setting the top value that the auxiliary variable can take; 
the AC50, which sets the concentration of LPS needed to reach 
50% of the maximum activation rate; the n Hill coefficient, which 
TaBle 6 | Estimated tumor necrosis factor synthesis rates depending on the 
amount of lipopolysaccharides (LPSs).
lPs (ng/ml) activation rate (h−1)
5 0.7043 · 10−2
0.25 0.5270 · 10−2
0.1 0.2359 · 10−2
0.05 0.1136 · 10−2
0.001 0.0000
TaBle 5 | Empirical activation rates depending on the amount of 
lipopolysaccharide (LPS).
lPs (ng/ml) activation rate (h−1)
5 4.6581
2 4.4318
1 3.7784
0.5 3.7100
0.1 1.5527
0.05 0.1177
0.005 0.0124
0.0005 0.0000
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describes the steepness of the curve; and the LPS concentration 
expressed as a stock variable. The immunomodulation depends 
directly on the amount of proinflammatory monocytes and the 
parameter immunomodulation rate (Table  2, Eq. 2). Similarly, 
LPS removal at a given time is directly proportional to the LPS 
concentration at that time and the LPS removal rate parameter 
(Table 2, Eq. 3).
Equation 4 of Table  2 expresses the TNF production that 
depends on the amount of proinflammatory monocytes, the aux-
iliary variable TNF synthesis rate, and the TD time delay in TNF 
parameter. Because the signaling cascade initiated after the bind-
ing of LPSs to the receptors in the plasmatic membrane leads to a 
delay between the time in which the resting monocytes are being 
activated and the production of TNF, the parameter TD time delay 
in TNF was incorporated to model this fact. In addition, TNFα 
expression in response to LPSs is regulated by the translocation 
of NF-κB to the nucleus. NF-κB translocation is highly dependent 
on the LPS concentration in the medium and it has been shown 
that the LPS-dose–response curve of NF-κB translocation follows 
a Hill equation (34). Therefore, in the model the TNF synthesis 
rate is modulated by a Hill activation function (Table 3, Eq. 2). 
This expression depends on: the maximum TNF synthesis rate, 
which is the top value that the auxiliary variable can take; the 
SC50 which sets the concentration of LPS needed to reach half 
of the maximum TNF synthesis rate; the m Hill coefficient which 
defines the slope of the curve; and the LPS concentration.
Because CCL2 is produced by the three subtypes of mono-
cytes at different rates, CCL2 production is represented by an 
equation that considers the three states, each of which is multi-
plied by its corresponding parameter (Table 2, Eq. 6). The TNF 
degradation and CCL2 degradation outflows are proportional to 
the mass in the source stock (TNF and CCL2, respectively) and 
the TNF degradation rate or CCL2 degradation rate parameters, 
respectively (Table 2, Eqs 5 and 7, respectively).
Parameterization, Optimization, and 
Validation of the Model
A model’s performance is highly dependent on its parameters. 
Thus, defining the values of the model’s parameters is one of 
the most important processes in system dynamics modeling. 
Although this model is relatively simple, the parameterization 
was challenging due to the uncertainty of the parameter values. 
As a consequence, there is a wide range of value combinations, 
many of which can result in unexpected model outputs far 
from the reality. To solve this problem, the parameters were 
sequentially estimated by isolating the different processes 
(e.g., activation, TNF production, CCL2 production, etc.) from 
the rest. Thus, the values were estimated by using the experi-
mental data from Figures 2–5. They were optimized following 
various approaches, such as non-linear regression analysis, the 
Vensim’s optimization tool, or using discrete models in Matlab 
to set the final values for the model parameters that are sum-
marized in Table  4. These approaches require to select initial 
values and ranging values for some parameters that are not being 
optimized in that moment. To this end, findings published in 
previous articles were used (6, 33, 34).
As described above, the Hill function to express the activation 
rate depends on the maximum activation rate, the AC50, and n 
parameters. To obtain the value for these three parameters, the 
activation rate was estimated for monocytes from healthy volun-
teers using various LPSs concentrations and following the experi-
mental design described in Figure 2A. Since TNF is produced by 
the proinflammatory subset of monocytes, this cytokine was used 
to indirectly estimate the percentage of cells that transit to the 
proinflammatory state after an LPSs challenge. Thus, the relative 
TNFα expression levels after a second LPSs challenge with 5 ng/ml 
LPS were used to estimate the percentage of resting monocytes 
that were not activated during the first stimulus (Figures 2B–F). 
As expected, when the time of the first challenge with LPS 
increased, there was a decrease in the fraction of cells remain-
ing in the resting state after the first challenge (Figures 2B–F). 
In addition, this decrease was faster when the LPS concentrations 
were higher (compare Figures  2B,F). The activation rates for 
each LPSs concentration were estimated from the adjusted one-
step decay functions obtained by non-linear regression analysis 
of the experimental data (Figures  2B–F) and are summarized 
in Table 5. Since the activation rates at super-low LPS doses are 
longer, the experimental design was slightly changed. Thus, the 
monocytes were first challenged with increasing concentrations 
of LPS, ranging from 0.5 pg/ml to 5 ng/ml, following the scheme 
of Figure 2G. The first stimulus was maintained for 16 h to sig-
nificantly reduce the relative expression of TNFα in the second 
challenge with 5 ng/ml LPS. The percentage of resting monocytes 
that were not activated during the first stimulus was estimated 
as described above. The activation rates for LPSs concentrations 
0.5, 5, and 50 pg/ml were calculated from a one-step decay func-
tion adjusted to pass through the experimental data that are also 
summarized in Table  5. Overall, these results showed that the 
LPS concentration highly impacted the activation rate (Table 5). 
Interestingly, no priming effect was observed in our system 
even with LPSs concentrations as low as 0.5 pg/ml (Figure 2H) 
or 0.05 pg/ml (data not shown). Graphic representation of the 
TaBle 7 | Variables in the extended model.
N Parameter equation/value range Units
1 Tolerance index 0–100 Dimensionless
2 Total monocytes User defined Monocytes
3 Initial resting  
monocytes
Total monocytes
Tolerance index
·
100
100
– Monocytes
4 Initial ET  
monocytes
Total monocytes
Tolerance index
·
100
Monocytes
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estimated activation rates from Table  5 in relation to the LPS 
concentration (Figure  3) showed a sigmoidal tendency that 
match with an activation Hill equation. Thus, the maximum 
activation rate, the AC50, and n parameters were obtained from 
the activation rate equation adjusted to fit the activation rates 
for each LPSs concentration (Figure  3) estimated from the 
experimental data shown in Table 5, which were set to 4.499/h, 
0.1889 ng/ml, and 1.4825, respectively. Thus, the half-maximal 
activation rate takes place when the LPS concentration equals 
AC50, and the almost maximal rate occurs when LPS quadruples 
the value of this parameter.
Similarly to the activation rate, the TNF synthesis rate expres-
sed as a Hill function depends on three parameters. To optimize 
the maximum TNF synthesis rate, the SC50 and the m parameters, 
the TNF synthesis rate was estimated using the Vensim’s optimi-
zation tool to fit the experimental data obtained from scenarios 
using various amounts of LPS (Figures  4A,B). As expected, 
the synthesis of TNF was highly dependent to the LPSs doses 
(Figure 4B) which led to different estimated TNF synthesis rates 
depending on the LPS concentration (Table 6). Representation of 
the estimated TNF synthesis rates (Table 6) showed a sigmoidal 
trend that indicated that the process can be explained by an acti-
vation Hill function (Figure 4C). The estimated values were used 
to adjust the Hill equation (Figure 4C) from which the maximum 
TNF synthesis rate, SC50, and m parameters were determined 
which were 0.0071  pg/h/monocytes, 0.1407  ng/ml, and 1.767, 
respectively. However, when these values were used to simulate 
the various scenarios, significant deviations between the model 
output and the experimental data were observed for lower LPSs 
doses (data not shown). In this sense, the values for maximum 
TNF synthesis rate and m were considered as definitive. However, 
the SC50 was further adjusted together with the immunomodula-
tion rate, LPS removal rate, and TNF degradation rate parameters 
(Table  4) using a discrete model built in Matlab to obtain the 
best fitting considering all scenarios from Figure 4B. Using the 
adjusted values (Table 4), the model highly reproduces the shape 
of the TNF curves obtained after simulation of isolated mono-
cytes from healthy volunteers with a wide range of LPSs doses 
(Figure 4B).
Similarly, to optimize the model parameters related to CCL2 
synthesis and degradation, a Matlab discrete model was used to 
fit the data from an experimental ET model obtained, following 
the design described in Figure 5A. In agreement with what has 
been previously published (19), ET monocytes showed a reduced 
capacity to produce TNF whereas CCL2 was upregulated 
(Figures 5B,C). As with the initial value of LPSs in the medium, 
factors related to the initial characteristics of the monocyte 
subsets have been set as user-defined. Therefore, setting differ-
ent values for these variables allows the simulation of particular 
scenarios, such as the response of ET monocytes to LPSs. 
To simulate the ET scenario, the model was programmed with 
0, 75,000, and 925,000 of the initial monocyte population in the 
resting, proinflammatory, and ET states, respectively, and then 
simulated with initial concentration of 5 ng/ml of LPS. The TNF 
curves obtained after simulation of the control and ET scenarios 
were similar to those observed in the cultures of monocytes 
(Figure 5B) which prove the fitness of the model and validate 
the optimization process of the TNF synthesis parameters 
explained above. The parameters CCL2 synthesis rate on resting, 
CCL2 synthesis rate on inflammation, CCL2 synthesis rate on 
ET, and CCL2 degradation rate were automatically optimized to 
fit the CLL2 levels measured in monocytes cultures (Figure 5C). 
As expected, both the TNF and CCL2 curves obtained after 
simulation of the ET scenario were markedly different from those 
obtained in a scenario programmed with all the monocytes in 
the resting state (Figures 5B,C, compare black and blue lines). 
Thus, the model showed a lower production of TNF and higher 
production of CLL2 when simulating the ET scenario compared 
with the control conditions. These results indicate that this model 
is able to reproduce the ET phenomenon.
Use of the Model: an example with septic 
Monocytes
Since initial monocyte population in the resting and ET levels 
can be considered dependent on each other, a tolerance index 
parameter was included in a modified version of the model. This 
parameter specifies the initial percentage of the initial mono-
cytes that are in ET and is used to calculate the initial population 
in ET and resting states (Table  7). Since the transition of the 
monocytes through the proinflammatory state is a rapid process, 
the initial proinflammatory monocytes value can be considered 
equal to 0.
To further analyze whether our model is able to simulate 
intermediate ET scenarios, monocytes from healthy volunteers 
were challenged with 0.5  ng/ml LPSs for 30  min and then 
incubated in fresh medium for 16  h allowing the culture to 
reach the ET (Figure 6A). Similar to results in Figure 5, this led 
to a decrease in the production of TNF and an increase in the 
production of CCL2 in comparison with the control scenario 
(Figures  6B,C, compare gray triangles with black circles). 
By setting the Tolerance index value in the model to 68%, the 
TNF and CCL2 outputs reproduce the cytokine curves obtained 
after a second LPS challenge with 5 ng/ml LPSs (Figures 6B,C), 
indicating that the model is able to reproduce different ET inten-
sities in monocyte cultures.
We and other authors have previously reported that mono-
cytes derived from patients with sepsis are in an ET state in 
which they show a diminished inflammatory response after 
ex vivo LPSs challenge (7, 8). Taking this into account, the 
model was programmed with a Tolerance index of 68%, and 
then simulated with initial concentration of 5  ng/ml of LPSs. 
The TNF and CCL2 levels at 16  h of simulation were similar 
to those observed in the cultures of monocytes isolated from 
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patients with sepsis and challenged with 5 ng/ml LPSs for 16 h 
(Figures  6D,E) reinforcing the idea that this model is able to 
reproduce the ET exhibited by cultured monocytes from patients 
with sepsis when they are challenged with LPSs, and that it could 
be used to determine the tolerance status of the monocytes of 
these patients.
DiscUssiOn
The immune system is able to initiate various types of responses, 
depending on the threat. Regulation of these responses involves 
the interaction of a high number of cell types, soluble mediators, 
and/or cell receptors. This complexity makes the immune system 
an excellent field in which to apply system dynamics, which 
has also been used for other biological science issues, such as 
exploring the dynamics of enzymatic reactions and improving 
the efficiency of bioreactors to be applied in the biotechnology 
industry (38, 39).
Monocyte/macrophage myeloid cells play major roles in the 
response of the innate immune system to endotoxins by initiating 
a protective inflammatory response that develops during time 
through various phases, from initiation and full inflammation to 
resolution, and re-establishment of tissue integrity. Although the 
response of monocytes to endotoxins and the ET phenomenon 
has been intensely studied in recent years, here we propose a 
mathematical model that improves our understanding, at a 
quantitative level, of this immunological process. The model 
considers that the endotoxin activates the resting monocytes 
that come into a transient inflammatory state, after which they 
move toward an ET condition. Because the inflammatory and ET 
monocytes produce various sets of cytokines in response to LPSs, 
we have included the levels of TNF as an inflammatory indica-
tor and CCL2 as a tolerant marker to indirectly distinguish the 
monocyte phenotypes.
The accurate quantification of the parameters is critical to 
model validity. Therefore, we combined experimental informa-
tion obtained from monocyte cultures challenged with LPSs with 
optimization processes to set the final values for the model param-
eters (Table 4). Among the factors influencing the response of 
the monocytes to endotoxins, the concentration of the endotoxin 
(e.g., LPSs) in the extracellular environment is known to be essen-
tial to the activation process (40). In the model, we assumed that 
the reduction in the extracellular LPSs led to a decrease in the rate 
of activation modulated by a Hill function, which has previously 
been used to reproduce activation activities in complex biologi-
cal systems such as the binding of transcription factors to DNA 
(41). In addition, the TNF synthesis rate modulation by the LPS 
concentration is also described by an activation Hill equation. 
Consequently, the model can reproduce experimental challenges 
using a wide range of LPSs doses (Figure 4). In this sense, the 
model shows that the amplitude and shape of the inflammatory 
phase is directly proportional to the strength and the extent of the 
external stimuli, indicating that it can simulate a wide variety of 
biological situations. For example, whereas stimulation of naive 
monocytes with high-dose LPSs induces a strong but relatively 
short inflammatory phase (as measured by the production of 
TNFα), the challenge with low-dose LPSs provokes a significantly 
lower inflammatory phase (Figure 4). Interestingly, by program-
ming a constant low-dose LPS (e.g., considering no LPS removal), 
the model is able to reproduce situations in which there is low-
grade inflammation for long time periods (data not shown), as 
occurs in chronic diseases including obesity and diabetes, and 
in cardiovascular and neurodegenerative pathologies (42–45). 
Note that although there are differences in the goodness for each 
independent scenario in Figure 4B, this can be explained because 
of the adjustment was performed considering the four scenarios 
at the same time.
Pretreatment of murine macrophages with super-low doses 
of LPS has been shown to result in a more robust cytokine 
production to a secondary LPSs challenge (20–22). In contrast, 
ex vivo stimulation of human monocytes isolated from healthy 
volunteers with LPS doses as low as 0.5 pg/ml (Figure 2H) or 
0.05  pg/ml (data not shown) did not significantly alter the 
response to a second LPSs challenge in the experimental system. 
In line with these results, Dillingh et al. proved that injection of 
very low doses of LPSs in human volunteers induced a reduction 
in TNFα and IL-1β production after an ex vivo LPS challenge 
to the isolated monocytes (24). This result can be explained by 
taking into account that humans are much more sensitive to LPSs 
than mice, and it strongly suggests that murine models are not 
the best option to study the response of human monocytes to 
endotoxins (23, 24).
This mathematical model has important implications for 
better understanding the dynamics of two physiological pro-
cesses, such as the inflammatory response and ET in humans. 
Previous mathematical models were experimentally calibrated 
by using datasets obtained from experiments using animals 
(28, 29). Altogether, this and our previous models clearly sug-
gest that although there are similarities, there are some differ-
ences in the response to endotoxins between humans and other 
animals. There are also implications in terms of simulating 
the response of monocytes to LPSs in a pathological scenario, 
such as that which occurs in sepsis, which is known to exhibit 
marked ET (7, 8) as a result of functional reprogramming medi-
ated by hypoxia-inducible factor-1α (46). ET scenarios can be 
simulated by adapting the initial values of the three monocyte 
subsets (Figure 5) or incorporating in the model the Tolerance 
index parameter (Figure  6) which allows us to set the initial 
ratio between the monocytes in the resting and ET states. 
Interestingly, the simulation output can be easily adjusted to the 
measured cytokine levels by varying the value of this parameter. 
Therefore, the Tolerance index can be used to determine the ET 
status of the monocytes from septic patients. Given that ET is 
associated with increased mortality and nosocomial infections 
in patients with sepsis, the Tolerance index could be used as 
a way to predict the risk of developing these complications 
(47–49). Nevertheless, the incorporation of other indicators 
involved in the immune response into the model could improve 
the model as potential prognostic tool to be used in the clinical 
setting.
Interestingly, a good practice in system dynamics modeling 
is to start with a simple model, whose complexity can be 
progressively increased by including new processes. In this 
sense, our model is presented in a modular and hierarchical 
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way, dividing the system into submodels with a similar level of 
complexity. This strategy facilitates the incorporation of new 
subsystems considering the production of other cytokines and/
or other mediators that are able to impact on the response to 
endotoxins. Therefore, other proinflamatory indicators, such as 
IL-6 and IL-1β, or anti-inflammatory, such as IL-10 and TGF-β, 
can be easily included as new subsystems in our model. The 
parameters of these subsystems could be estimated following 
an experimental approach similar to the one used for TNFα 
and CCL2. Other example is that our model only considers 
LPS as stimulator but subsystems for other molecules affecting 
the activation flow of the monocytes might be incorporated. 
Experimentally this new process could be parameterized and 
optimized in a similar way that the one performed in Figures 2 
and 3.
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